Evaluation of Novel Sansalvamide A Derivatives as Potential Anti-Cancer Agents
$177,052U54FY2008CANIH
University Of California, San Diego, La Jolla CA
Investigators
Linked publications & trials
Paper 39185782Paper 39108239Paper 39108235Paper 39029743Paper 38733143Paper 38699999Paper 38656373Paper 38306034Paper 38186234Paper 37843700Paper 37773474Paper 37459573Paper 37195591Paper 36999972Paper 36901173Paper 36871334Paper 36848036Paper 36828176Paper 36767078Paper 36377803Paper 36376642Paper 36357323Paper 36214671Paper 36197902Paper 36150447Paper 36107798Paper 36069964Paper 35975911Paper 35917201Paper 35895062Paper 35657499Paper 35247884Paper 35078240Paper 35010795Paper 35010632Paper 34845070Paper 34697054Paper 34652935Paper 34529834Paper 34409873Paper 34363574Paper 34321282Paper 34209191Paper 34108139Paper 34058256Paper 34039570Paper 33893616Paper 33892497Paper 33788793Paper 33644299Paper 33534647Paper 33454764Paper 33198142Paper 33153273Paper 33141207Paper 32788725Paper 32771406Paper 32729927Paper 32583884Paper 32466687Paper 32445643Paper 32428708Paper 32276222Paper 32202155Paper 32178638Paper 32153233Paper 31869219Paper 31861788Paper 31816298Paper 31749376Paper 31728922Paper 31605514Paper 31479529Paper 31147314Paper 31076896Paper 30915656Paper 30809741Paper 30518973Paper 30440015Paper 30414276Paper 30333222Paper 30267713Paper 30249606Paper 29636378Paper 29497815Paper 29211840Paper 29190761Paper 28931759Paper 28810432Paper 28752364Paper 28698973Paper 28634873Paper 28627370Paper 28520484Paper 28380627Paper 28376229Paper 28359166Paper 28221018Paper 28214970Paper 28201999
View original record on NIH RePORTER →